Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-17

Clinical Trial Update: Tetracycline Treatment Tolerability Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is updating on the tolerability of tetracycline treatment for Post-Treatment Lyme Disease. Enrollment is by invitation and sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tetracycline (tetracycline)

Snippet

Sponsor: Johns Hopkins University | Conditions: Post-Treatment Lyme Disease | Phase 2 | Status: ENROLLING_BY_INVITATION